A Stanford Medicine-led, international study of hundreds of samples from patients with Hodgkin lymphoma has shown that levels of tumor DNA circulating in their blood can identify who is responding well to treatment and others who are likely to experience a disease recurrence -; potentially letting some patients who are predicted to have favorable outcomes forgo lengthy treatment.
Surprisingly, the study also revealed that Hodgkin lymphoma, a cancer of the lymph nodes, can be divided into two groups, each with distinct genetic changes and slightly different prognoses. These changes hint at weaknesses in the cancer's growth mechanisms that could be targeted by new, less toxic therapies.
The idea of establishing molecular profiles of tumors is not new. But unlike other cancers, Hodgkin lymphoma has resisted these types of analyses. That's because Hodgkin lymphoma cells are relatively scarce -; even within a large tumor.
This approach offers our first significant look at the genetics of classical Hodgkin lymphoma. Compared with other cancers, finding Hodgkin lymphoma cancer cells or cancer DNA to study is like searching for a needle in a haystack. A patient can have a football-sized tumor in their chest, but only about 1% of the cells in the mass are cancer cells, with the remainder representing an inflammatory response to the tumor. This has made it very difficult to find the smoking guns that drive the disease."
Ash Alizadeh, MD, PhD, professor of medicine, Stanford
Alizadeh, who is the Moghadam Family Professor, and Maximilian Diehn, MD, PhD, professor of radiation oncology and the Jack, Lulu, and Sam Willson Professor, are the senior authors of the research, which will be published Dec. 11 in Nature. Former postdoctoral scholar Stefan Alig, MD; instructor of medicine Mohammad Shahrokh Esfahani, PhD; and graduate student Andrea Garofalo are the lead authors, as is graduate student Michael Yu Li at British Columbia Cancer.
About 8,500 people are diagnosed with Hodgkin lymphoma each year in the United States. The disease primarily affects people between the ages of 15 and 35, and people older than 55.
Just over 60 years ago, Stanford radiologist Henry Kaplan, MD pioneered the use of targeted radiation to treat Hodgkin lymphoma. The new therapy, delivered by a high-energy linear accelerator Kaplan developed in the 1950s for medical use, was the first step in a Stanford-driven effort to turn the once fatal cancer of the lymph nodes into one that is now highly curable. Soon thereafter, Kaplan was joined by medical oncologist Saul Rosenberg, MD, and the two worked out ways to combine radiation therapy with chemotherapy regimens, including one known simply as the Stanford 5 (named because it was the fifth in a series of gradually less toxic treatments).
During the subsequent decades, however, the genetic changes that cause the cancer have remained mysterious. That's because, unlike many other cancers, Hodgkin lymphoma tumors are made up primarily of immune cells that have infiltrated the cancer, making it difficult to isolate the diseased cells for study. Today, patients are treated with chemotherapy, radiation or a combination of both; about 89% of patients survive five years or more after their initial diagnosis.
Alizadeh, Diehn and their colleagues used an optimized DNA sequencing technique called PhasED-Seq, or phased variant enrichment and detection sequencing, they developed at Stanford Medicine in 2021 to home in on vanishingly rare bits of DNA in a patient's bloodstream to identify genetic changes that drive the growth of Hodgkin lymphoma.
PhasED-Seq builds upon a technique called CAPP-Seq, or cancer personalized profiling by deep sequencing, developed in 2014 by Alizadeh and Diehn to assess lung cancer levels and response to treatment. But PhasED-Seq is much more sensitive.
"CAPP-Seq could detect as few as one cancer DNA sequence in 10,000 non-cancer DNA sequences," Diehn said. "But PhasED-Seq can detect less than one cancer DNA sequence in 1 million non-cancer DNA sequences."
Their goal was to learn more about what drives the cancer and how to make successful treatments even easier for patients.
"We typically can cure most patients with one line of therapy," Alizadeh said. "But we are always trying to figure out less toxic chemotherapeutic agents that are gentler to the bone marrow, lungs and other organs, and ways to more precisely target radiation therapy. And a small minority of patients experience a recurrence that can be challenging to treat successfully."
The researchers used CAPP-Seq and PhasED-Seq to analyze blood samples from 366 people treated for Hodgkin lymphoma at three medical centers including Stanford Medicine. The technique was remarkably sensitive.
"Surprisingly, we detected more cancer DNA in the blood than in the cancer tissue itself," Alizadeh said. "That seemed hard to believe until we had analyzed enough samples to show that it was reproducible."
The researchers used machine learning techniques to categorize the different types of genetic changes present in the cancer cells. They found that patients could be separated into two groups: one that predominantly has mutations in several cancer-associated genes implicated in cellular survival, growth and inflammation, and another with a type of genetic change called copy number alterations that affects larger swathes of the genome, subbing in or excising regions of DNA that influence cell growth and cancer.
"We adapted a method from natural language processing to find these two Hodgkin subtypes, and then used a variety of methods to identify key biological and clinical features and to confirm that the subtypes are also seen in other groups of patients," Esfahani said.
The first group, which makes up about one-half to two-thirds of patients, occurs primarily in younger patients and has a comparatively more favorable outcome. About 85-90% of these people survive for three years without disease recurrence. The second, which makes up about one-half to one-third of the total, occurs in both younger and older patients and has a less favorable, although still good outcome. About 75% of these people live for at least three years without recurrence.
Critically, a subset of both groups contained a unique mutation in a gene for the receptor for cellular signaling proteins called interleukin 4 and interleukin 13.
"We discovered a new class of mutations in the interleukin 4 receptor gene that enhance a key pathway characteristic to Hodgkin lymphoma," Alig said. "These mutations may be indicative of unique vulnerabilities of the tumor that can be exploited therapeutically."
The researchers also showed that patients who had no detectable circulating tumor DNA in their blood shortly after starting treatment were much less likely to have disease recurrence than those who had even small amounts of residual circulating cancer DNA at the same time point -; a distinction researchers had hoped to see, but were unsure about being able to detect even with PhasED-Seq.
"I was surprised that we could predict which patients would recur," Diehn said. "Even with our ultrasensitive assay there was a significant chance that the signal from the cancer DNA could become undetectable after treatment, even in patients who eventually recurred. But this didn't happen."
The researchers seeking to understand more about the biology of Hodgkin lymphoma have one key goal: the improvement of care for patients.
"The number of people who experience recurrence is small, but, like Henry Kaplan and Saul Rosenberg, we want to save every one of them," Diehn said. "They would have been amazed and gratified by these findings, which build upon their important work from decades ago. We look forward to an era in which we can cure every patient with no toxicity."
Researchers from British Columbia Cancer, University Hospital Franois Mitterand, St. Jude Children's Research Hospital, the Oncology Institute of Southern Switzerland, KU Leuven, the University of Strasbourg, Emory University, the Fred Hutchinson Cancer Research Center, the Hospices Civils de Lyon, and the Universit Catholique de Louvain contributed to the work.
This work was supported by the National Institutes of Health (grants R01CA257655, R01CA233975 and R03CA21765), the Department of Defense, the Virginia and D.K. Ludwig Fund for Cancer Research, a Hanna and Michael Murphy family gift, the Stanford Cancer Institute, the Damon Runyon Cancer Research Foundation, an American Society of Hematology Scholar Award, the V Foundation for Cancer Research, the Emerson Collective Cancer Research Fund, a Stinehart/Reed Award, the CRK Faculty Scholar Fund, the Lung Cancer Research Foundation and the SDW/DT, the Shanahan Family Foundations, the Terry Fox Research Institute, the Canadian Institutes of Health Research, an Elizabeth C. Watters Research Fellowship, and the American Syrian Lebanese Associated Charities.
Diehn, Alizadeh, Alig and Esfahani have filed patents related to cancer biomarkers. Diehn has multiple issued and pending patents licensed to Foresight Diagnostics and Roche. He holds interests in CiberMed, Inc.; Foresight Diagnostics; and Gritstone Bio. Alizadeh has multiple issued and pending patents licensed to Foresight Diagnostics, CiberMed Inc. and Idiotype Vaccines. He holds interests in CiberMed, Inc.; Foresight Diagnostics; FortySeven Inc.; and CARGO Therapeutics.
Source:
Journal reference:
Alig, S. K., et al. (2023). Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature. doi.org/10.1038/s41586-023-06903-x.
Original post:
Study reveals genetic roots of hodgkin lymphoma, offering hope for new treatments - News-Medical.Net
- Introgression and disruption of migration routes have shaped the genetic integrity of wildebeest populations - Nature.com - April 15th, 2024 [April 15th, 2024]
- Is Left-Handedness Tied to Your Genetics? Possibly, New Study Suggests - Technology Networks - April 15th, 2024 [April 15th, 2024]
- A pan-genome of 69 Arabidopsis thaliana accessions reveals a conserved genome structure throughout the global ... - Nature.com - April 15th, 2024 [April 15th, 2024]
- Clemson researchers pave the way for precision medicine with AI - Clemson News - April 15th, 2024 [April 15th, 2024]
- ACMG Foundation for Genetic and Genomic Medicine Elects Four Highly Accomplished Medical Genetics ... - PR Newswire - April 15th, 2024 [April 15th, 2024]
- Katie Gallagher MS '15, CGC Named Director of the Joan H. Marks Graduate Program in Human Genetics at Sarah ... - Sarah Lawrence College - April 15th, 2024 [April 15th, 2024]
- The genomic architecture of inherited DNA variants - Baylor College of Medicine | BCM - April 15th, 2024 [April 15th, 2024]
- Clemson genetics major named Truman Scholar for her work in combatting rare diseases - ABC NEWS 4 - April 15th, 2024 [April 15th, 2024]
- Otago University Discovers Cause of Rare Genetic Condition - Mirage News - April 15th, 2024 [April 15th, 2024]
- Genetic Analysis Guides Conservation of Endangered Bumble Bee - Entomology Today - April 15th, 2024 [April 15th, 2024]
- First insights into the genetic bottleneck characterizing early sheep husbandry in the Neolithic period - EurekAlert - April 15th, 2024 [April 15th, 2024]
- Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease - Nature.com - April 7th, 2024 [April 7th, 2024]
- A deep dive into the genetics of alcohol consumption - Medical Xpress - April 7th, 2024 [April 7th, 2024]
- Right-wing authoritarianism appears to have a genetic foundation - PsyPost - April 7th, 2024 [April 7th, 2024]
- UC Irvine-led research team builds first tandem repeat expansions genetic reference maps - UCI News - April 7th, 2024 [April 7th, 2024]
- A Deep Dive Into the Genetics of Alcohol Consumption - University of California San Diego - April 7th, 2024 [April 7th, 2024]
- Untold story of bird evolution revealed through genetics - Earth.com - April 7th, 2024 [April 7th, 2024]
- Genetic Test for Opioid Addiction Risk Should Be Withdrawn, Experts Tell FDA - Medpage Today - April 7th, 2024 [April 7th, 2024]
- Scientists Discover 17 New Genetic Variants Linked to Alzheimer's Disease - SciTechDaily - April 7th, 2024 [April 7th, 2024]
- An hereditary liver disease cured with the help of gene scissors - EurekAlert - April 7th, 2024 [April 7th, 2024]
- World Anthropology Day showcases multifaceted programs | Binghamton News - Binghamton University - April 7th, 2024 [April 7th, 2024]
- Resilience to periodic disturbances and the long-term genetic stability in Acropora coral | Communications Biology - Nature.com - April 7th, 2024 [April 7th, 2024]
- Rare genetic variants found to have a large impact on obesity risk - Drug Target Review - April 7th, 2024 [April 7th, 2024]
- INTERACT COALITION FORMED TO ADVANCE PATIENT ACCESS TO GENETIC TESTING FOR HEREDITARY ... - PR Newswire - April 7th, 2024 [April 7th, 2024]
- Christensen Genetics - AG INFORMATION NETWORK OF THE WEST - AGInfo Ag Information Network - April 7th, 2024 [April 7th, 2024]
- New form of EDS identified by mutation in THBS2 gene - Ehlers-Danlos News - April 7th, 2024 [April 7th, 2024]
- Genetics of estrogen production linked to endometrial cancer risk in postmenopausal women - News-Medical.Net - February 13th, 2024 [February 13th, 2024]
- Cord Blood Registry (CBR) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - PR Newswire - February 13th, 2024 [February 13th, 2024]
- Gene Variant Linked to Lower Levels of Hormonal Birth Control - The Scientist - February 13th, 2024 [February 13th, 2024]
- CooperSurgical, Fulgent partner on genetic screening panels - Medical Device Network - February 13th, 2024 [February 13th, 2024]
- UM Today | Faculty of Science | The intersection of genetics and advocacy - UM Today - February 13th, 2024 [February 13th, 2024]
- Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever - Nature.com - February 13th, 2024 [February 13th, 2024]
- Secrets of human genetics could optimize medical care - Earth.com - February 13th, 2024 [February 13th, 2024]
- Significance of genetic mutations in toxic tort cases - Rhode Island Lawyers Weekly - February 13th, 2024 [February 13th, 2024]
- Why Should Farmers Invest in New Genetics? A Recent Panel Discussion Offered Some Good Reasons - Seed World - February 13th, 2024 [February 13th, 2024]
- The Role of Genetics and Maternal Factors in Retinopathy of Prematurity: A Comparative Study - Medriva - February 13th, 2024 [February 13th, 2024]
- 'The Idea That Who You Are Is Only Genetics Is the Essence of Evil' - Books - Haaretz - February 13th, 2024 [February 13th, 2024]
- IPK researchers provide genetic explanations for shade-induced biomass allocation in wheat - EurekAlert - February 13th, 2024 [February 13th, 2024]
- River Valley Beef Cattle Conference to explore state of hay availability, cattle genetics and more - Stuttgart Daily Leader - February 13th, 2024 [February 13th, 2024]
- Harnessing human evolution to advance precision medicine - EurekAlert - February 13th, 2024 [February 13th, 2024]
- Twins are a mirror to each other and a window into the mysteries of genetics - WAMU 88.5 - February 13th, 2024 [February 13th, 2024]
- Unveiling the Disparity in Cardiovascular Health: Biological Factors, Dyslipidemia, and Genetics - Medriva - February 13th, 2024 [February 13th, 2024]
- Parental traits offer new clues to predicting neurodevelopmental disorders in children - News-Medical.Net - February 13th, 2024 [February 13th, 2024]
- Cheetahs Are Extremely Inbred: 50 Interesting Genetics Facts You May Have Missed At School - Bored Panda - February 4th, 2024 [February 4th, 2024]
- Five Best: Books on Genetics - WSJ - The Wall Street Journal - February 4th, 2024 [February 4th, 2024]
- 4 new US sites added to global Parkinson's genetics study - Parkinson's News Today - February 4th, 2024 [February 4th, 2024]
- Animal Genetics Market revenue to exceed USD 43.4 Billion by 2036, says Research Nester - Yahoo Finance - February 4th, 2024 [February 4th, 2024]
- Nobel Laureate and World-Renowned Geneticist to Speak at 2024 Commencement - News Center - Feinberg News Center - February 4th, 2024 [February 4th, 2024]
- Efforts are underway to improve genetics in cattle herds to better sustainability - RFD-TV - February 4th, 2024 [February 4th, 2024]
- First report on the molecular phylogenetics and population genetics of Aedes aegypti in Iran - Parasites & Vectors - Parasites & Vectors - February 4th, 2024 [February 4th, 2024]
- What can your DNA say about your risk of opioid addiction? - National Geographic - February 4th, 2024 [February 4th, 2024]
- The Born in Guangzhou Cohort Study enables generational genetic discoveries - Nature.com - February 4th, 2024 [February 4th, 2024]
- Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics - PR Newswire - February 4th, 2024 [February 4th, 2024]
- Rare disorder causing extra fingers and toes identified - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Retinal OCT and Genetics Identify Links Between Ocular and Systemic Health - Photonics.com - February 4th, 2024 [February 4th, 2024]
- Researchers discover mechanism that protects tissue after faulty gene expression - News-Medical.Net - February 4th, 2024 [February 4th, 2024]
- Genetics or lifestyle: What makes the greatest difference in health? - Agweek - February 4th, 2024 [February 4th, 2024]
- Why Some Folks Get COVID, and Others Never Do - HealthDay - February 4th, 2024 [February 4th, 2024]
- From plant genetics to fresh produce to be showcased in Berlin - FreshPlaza.com - February 4th, 2024 [February 4th, 2024]
- Adolescent Stress Alters Brain Genes, Affecting Adult Behavior - Neuroscience News - February 4th, 2024 [February 4th, 2024]
- Significance of genetic mutations in toxic tort cases - Massachusetts Lawyers Weekly - February 4th, 2024 [February 4th, 2024]
- New genetic test in England aims to make blood transfusions safer - Sickle Cell Disease News - February 4th, 2024 [February 4th, 2024]
- Unlocking tree genetic diversity: advanced hyperspectral phenotyping for enhanced Scots pine selection - EurekAlert - January 19th, 2024 [January 19th, 2024]
- The Role of Genetics in Cancer Care Continues to Expand - OncLive - January 19th, 2024 [January 19th, 2024]
- Family faces multiple diagnoses for genetic condition NF1 - Sanford Health News - January 19th, 2024 [January 19th, 2024]
- Unique gene variants tied to glaucoma found in Black patients - Livescience.com - January 19th, 2024 [January 19th, 2024]
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics - GlobeNewswire - January 19th, 2024 [January 19th, 2024]
- Reflections on the Idea of Social and Behavioral Genetics - The Hastings Center - January 19th, 2024 [January 19th, 2024]
- Building trust and saving lives: A community approach to genetic education - Medical University of South Carolina - January 19th, 2024 [January 19th, 2024]
- SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India India ... - PR Newswire - January 19th, 2024 [January 19th, 2024]
- 2024 Brevant Brand Corn Class Offers New Genetics and Traits - CropLife - January 19th, 2024 [January 19th, 2024]
- Genetics Reveal Poor Oral Health in Mesolithic Era - Mirage News - January 19th, 2024 [January 19th, 2024]
- Nova Siri Genetics strengthens its presence in Huelva, growing by 34% - FreshPlaza.com - January 19th, 2024 [January 19th, 2024]
- Controversial New Research Find That Bisexuals Are a Bunch of Rascals - Futurism - January 8th, 2024 [January 8th, 2024]
- Mayo Clinic Q&A: Weight loss and genetics - Chicago Tribune - January 8th, 2024 [January 8th, 2024]
- Nutrigene Launches Personalised Development Program to Intersect Genetics and Learning through DNA - JCN Newswire - January 8th, 2024 [January 8th, 2024]
- The DNA of privacy and the privacy of DNA - Federal Trade Commission News - January 8th, 2024 [January 8th, 2024]
- Development of a human genetics-guided priority score for 19365 genes and 399 drug indications - Nature.com - January 8th, 2024 [January 8th, 2024]
- Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 221% Above Its Share Price - Yahoo Finance - January 8th, 2024 [January 8th, 2024]
- Educational attainment of East Asians are linked to genetics - KBR - January 8th, 2024 [January 8th, 2024]